• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDOS INTERNATIONAL SARL DELTAPAQ CERE 2MMX10CM; NEUROVASCULAR EMBOLIZATION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDOS INTERNATIONAL SARL DELTAPAQ CERE 2MMX10CM; NEUROVASCULAR EMBOLIZATION DEVICE Back to Search Results
Model Number CDF100210-30
Device Problem Positioning Problem (3009)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 08/12/2020
Event Type  malfunction  
Manufacturer Narrative
Product complaint # (b)(4).Procode: krd/hcg.The device is available to be returned for evaluation and testing.However, it has not been received to date as indicated as ¿other¿ in this section as the reason for non-evaluation.If the device returns, a device investigation will be performed.A supplemental report will be submitted if new facts arise which materially alter information submitted in a previous mdr report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Event Description
As reported by the field, during a coil embolization, a 2mmx10cm deltapaq cere coil (cdf10021030, s13731) was being used as the third coil.The physician didn't like the shape of the coil deployment and decided to pull it out.During resheathing, the coil introducer failed to be re-zipped.The physician used a same like product.The procedure was successfully finished.
 
Manufacturer Narrative
Product complaint # (b)(4).A supplemental report will be submitted if new facts arise which materially alter information submitted in a previous mdr report.Complaint conclusion: as reported by the field, during a coil embolization, a 2mmx10cm deltapaq cere coil (cdf10021030, s13731) was being used as the third coil.The physician didn't like the shape of the coil deployment and decided to pull it out.During resheathing, the coil introducer failed to be re-zipped.The physician used a same like product.The procedure was successfully finished.A non-sterile unit deltapaq cere 2mmx10cm was received inside of a pouch.The device was inspected, and it was found that the dpu is protruded from the introducer, no other damages or anomalies were observed during the visual analysis.The embolic coil was inspected under a microscope and it was found with a stretch condition.No other damages or anomalies were observed during the microscopic inspection.The functional analysis could not be performed due to the stretch condition noted on the embolic coil and the protruded condition noted the dpu.A manufacturing record evaluation was performed for the finished device s13731number, and no non-conformances related to the reported complaint condition were identified the complaint reported by the customer ¿coil introducer - zipping difficulty-rezipping¿ was confirmed, during the inspection, it was noted that the dpu is protruded from the introducer, also it was noted that the embolic coil has a stretch condition.Due to these conditions, the complaint reported by the customer can be confirmed.The protruded condition noted on the dpu is related with the customer¿s complaint however it cannot be determined exactly when this condition appeared.The complaint reported by the customer ¿coil - positioning difficulty-poor conformability¿ could not be evaluated because the complaint reported by the customer is specific to the patient and procedure at the time of occurrence and cannot be replicated in the lab.The stretch condition noted on the embolic coil may have been related with compliant, however, this cannot be conclusively determined.The stretched condition noted on the embolic coil could be related with the complaint, the condition appears to might have been caused by excessive force and handling being applied to the device however none of those can be conclusively determined.Neither the analysis nor the mre suggests that the failure reported by the customer could be related to the manufacturing process.The instructions for use (ifu) instructs the user to unsheathe a small length of the dpu to unlock the device, then to advance the embolic coil into the microcatheter until the hub connector of the dpu reaches the proximal end of the resheathing tool.This results in the placement of the embolic coil and the more flexible and fragile distal sections of the dpu inside the microcatheter before continuing to unsheathe the device.If the device is unsheathed before advancing into the microcatheter, there is a risk that the embolic coil or the distal end of the dpu will be unsheathed and pass through the resheathing tool.If the resheathing tool passes over the distal end of the dpu, this will expose these flexible sections, which will then be subject to kinking and bending.Once a part of the dpu is kinked or bent, the translucent introducer sheath will not be able to re-form around it, and that section of the device will protrude.The ifu also instructs on proper positioning of the microcoil system.The ifu also warns: ¿if repositioning of the microcoil is necessary, carefully observe the motion of the microcoil in respect to the dpu wire while retracting the microcoil under fluoroscopy.If the microcoil movement is not one-to-one with the dpu wire, or if repositioning is difficult, the microcoil may have become stretched and could possibly break.Gently remove and discard the microcoil system¿.Assignment of root cause for the events remains speculative and inconclusive, based on the limited information provided and the evidence presented by the returned device; however, it is possible that clinical and procedural factors, including device manipulation and device interaction, may have contributed to the reported failures and damages on the returned system.Multiple attempts to obtain additional information were unsuccessful.If information is provided at a later date, the file will be reopened and processed accordingly.As part of the post market surveillance program, information from this complaint is trended to identify statistical signals for consideration of further correction action.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no corrective actions will be taken at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DELTAPAQ CERE 2MMX10CM
Type of Device
NEUROVASCULAR EMBOLIZATION DEVICE
Manufacturer (Section D)
MEDOS INTERNATIONAL SARL
chemin-blanc 38
le locle neuchatel CH-24 00
SZ  CH-2400
MDR Report Key10477745
MDR Text Key227626646
Report Number3008114965-2020-00394
Device Sequence Number1
Product Code HCG
UDI-Device Identifier00878528007111
UDI-Public00878528007111
Combination Product (y/n)N
PMA/PMN Number
K080437
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 08/12/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/01/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2022
Device Model NumberCDF100210-30
Device Catalogue NumberCDF10021030
Device Lot NumberS13731
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/08/2020
Date Manufacturer Received10/08/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-